Page last updated: 2024-08-24

lercanidipine and Leukemia, Myeloid, Acute

lercanidipine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Benetton, M; Bisio, V; Borella, G; Borile, G; Bresolin, S; Buldini, B; Cairo, S; Campodoni, E; Cani, A; Da Ros, A; Leszl, A; Locatelli, F; Marchetti, A; Michielotto, B; Montesi, M; Montini, B; Pigazzi, M; Porcù, E; Sandri, M; Tregnago, C1

Other Studies

1 other study(ies) available for lercanidipine and Leukemia, Myeloid, Acute

ArticleYear
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Blood, 2021, 08-19, Volume: 138, Issue:7

    Topics: Calcium Channels, L-Type; Cell Proliferation; Dihydropyridines; Human Umbilical Vein Endothelial Cells; Humans; Leukemia, Myeloid, Acute; Mesenchymal Stem Cells; Neoplasm Proteins; Transcriptome; Tumor Cells, Cultured; Tumor Microenvironment

2021